Donate to blood
cancer research
Over 19,400 Australians are diagnosed with blood cancer.
Donate today towards blood cancer research
It is estimated that 19,400 cases of blood cancers such as leukaemia, lymphoma and myeloma, will be diagnosed in Australia this year alone.
Cure Cancer has funded 42 blood cancer researchers so far, but more research is desperately needed. Supporting the brightest emerging researchers with innovative ideas gives us the best possible chance of finding a cure.
Every dollar you donate makes a real difference to our mission. Together, we can cure cancer
"Without an established track record in obtaining research grants, it can be near impossible to get one’s foot in the door in many funding schemes. Cure Cancer grants are so highly competitive, as reflected in the high calibre of their recipients. I’m honoured to have been selected – I view it as one of my greatest career achievements to date!"
— Dr Kate Van Dyke, a Cure Cancer grant recipient
How your donation helps
$75
Can help fund an hour of research
$125
Can help fund microscopy imaging to look for immune cells in tumours
$550
Can help fund lab supplies for up to ten vital experiments
$1,000
Can help provide cutting-edge software to analyse cells
Frequently asked questions
What is blood cancer?
Blood cancer occurs when normal blood cell production, which happens in the bone marrow, is interrupted by the uncontrolled growth of an abnormal type of blood cell. When abnormal blood cells build up in the blood, it can affect how the rest of the body functions.
Blood cancer is the second most common cancer diagnosis and also the second most common cause of cancer-related deaths in Australia in the latest national report. Although incidence for most cancer types have largely improved over the years, blood cancer remains an exception. Incidence of this type of cancer continues to grow, and it is up to 47% in the last 10 years alone.
What are the types of blood cancer?
Leukaemia
Leukaemia starts in the bone marrow where developing blood cells (usually white cells) undergo a malignant change. These cells then crowd the marrow, affecting the body’s ability to produce normal blood cells. There are four kinds of leukaemia: acute lymphoblastic, acute myeloid, chronic lymphocytic, and chronic myeloid. In 2021, an estimated 2,029 deaths in Australia were due to leukaemia. The five-year survival rate has significantly improved in the last twenty years, from 43% in 1988-1992 to 63% in 2013-2017.
Symptoms can include:
-
Signs of anaemia
-
Chronic infection (such as fevers, sweats, sores)
-
Enlarged lymph nodes
-
Joint pain
- Spontaneous bruising and increased bleeding
- Painful passing of urine
Lymphoma
Lymphomas affect the lymphatic system, part of the immune system which protects the body against disease and infection. These occur when lymphocytes (a type of white blood cell) undergo a malignant change and multiply in an uncontrolled way. The lymphoma cells then accumulate to form tumours in the lymph nodes, which are located throughout the body. There are two types of lymphoma: Hodgkin lymphoma and non-Hodgkin lymphoma, which can be distinguished by the specific lymphocytes involved.
Symptoms can include:
-
Swelling of lymph nodes
-
Fever
-
Night sweats
- Sudden weight loss
- Fatigue
- Shortness of breath
Myeloma
Myeloma develops in plasma cells (a type of white cell) of the bone marrow. It is often called multiple myeloma because marrow is found in multiple bones such as the spine, skull, ribs, pelvis, and shoulder. The five-year survival rate for myeloma is 51%.
Symptoms can include:
-
Kidney problems
-
Frequent nose bleeding
-
Feeling pain in the bones
-
Fatigue
-
Chronic infections that don’t go away
What are the risks associated with blood cancer?
Exposure to radiation and certain chemicals or solvents is a known risk associated with leukaemia, lymphoma, and myeloma. Infection of HIV, which can weaken the immune system, Epstein-Barr virus (herpes), and Human T-Cell leukaemia virus, can also increase risk.
People assigned male at birth are at a slightly greater risk of lymphoma. Having a family history of Hodgkin lymphoma increases the risk of this disease. This is also more common in early adulthood (people in their 20s). Non-Hodgkin lymphoma is more common in late adulthood (60 above).
Our blood cancer researchers
Together, we can cure cancer.
Let's stay in touch
To receive updates on our work, campaigns and our impact in cancer research, subscribe to our newsletter.